Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Feb. 12, 2024, 10:08 UTC
  • 47
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

AKORN

  • FDA Approval
  • Feb. 12, 2024, 10:08 UTC
  • 50
  • 0 comments

FDA approve ACETAMINOPHEN; CODEINE PHOSPHATE

Comment Full text

ACTAVIS LABS UT INC

  • FDA Approval
  • Feb. 12, 2024, 10:08 UTC
  • 45
  • 0 comments

FDA approve TESTOSTERONE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Feb. 12, 2024, 09:50 UTC
  • 47
  • 0 comments

FDA approve DEFLAZACORT

Comment Full text

NOVARTIS

  • FDA Approval
  • Feb. 09, 2024, 18:26 UTC
  • 42
  • 0 comments

FDA approve NILOTINIB HYDROCHLORIDE

Comment Full text

ORGANON

  • FDA Approval
  • Feb. 09, 2024, 18:26 UTC
  • 48
  • 0 comments

FDA approve EZETIMIBE; SIMVASTATIN

Comment Full text

GENZYME

  • FDA Approval
  • Feb. 09, 2024, 18:05 UTC
  • 46
  • 0 comments

FDA approve ALEMTUZUMAB

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Feb. 09, 2024, 18:05 UTC
  • 42
  • 0 comments

FDA approve SODIUM ZIRCONIUM CYCLOSILICATE

Comment Full text

SLAYBACK PHARMA LLC

  • FDA Approval
  • Feb. 09, 2024, 18:05 UTC
  • 43
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text

ALEXION PHARM

  • FDA Approval
  • Feb. 09, 2024, 17:46 UTC
  • 39
  • 0 comments

FDA approve ECULIZUMAB

Comment Full text
  • Previous
  • 555
  • 556
  • 557
  • 558
  • 559
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183587)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin